Literature DB >> 25190077

Divergent antiviral roles of amphibian (Xenopus laevis) macrophages elicited by colony-stimulating factor-1 and interleukin-34.

Leon Grayfer1, Jacques Robert2.   

Abstract

Macrophages are integral to amphibian immunity against RVs, as well as to the infection strategies of these pathogens. Although CSF-1 was considered to be the principal mediator of macrophage development, the IL-34 cytokine, which shares no sequence identity with CSF-1, is now believed to contribute to vertebrate monopoiesis. However, the respective roles of CSF-1- and IL-34-derived macrophages are still poorly understood. To delineate the contribution of these macrophage populations to amphibian immunity against the RV FV3, we identified the Xenopus laevis IL-34 and transcriptionally and functionally compared this cytokine with the previously identified X. laevis CSF-1. The X. laevis CSF-1 and IL-34 displayed strikingly nonoverlapping developmental and tissue-specific gene-expression patterns. Furthermore, only CSF-1 but not IL-34 was up-regulated in the kidneys of FV3-challenged tadpoles. Intriguingly, recombinant forms of these cytokines (rXlCSF-1, rXlIL-34) elicited morphologically distinct tadpole macrophages, and whereas rXlCSF-1 pretreatment decreased the survival of FV3-infected tadpoles, rXlIL-34 administration significantly prolonged FV3-challenged animal survival. Compared with rXlIL-34-elicited macrophages, macrophages derived by rXlCSF-1 were more phagocytic but also significantly more susceptible to in vitro FV3 infections. By contrast, rXlIL-34-derived macrophages exhibited significantly greater in vitro antiranaviral activity and displayed substantially more robust gene expression of the NADPH oxidase components (p67(phox), gp91(phox)) and type I IFN. Moreover, FV3-challenged, rXlIL-34-derived macrophages exhibited several orders of magnitude greater up-regulation of the type I IFN gene expression. This marks the first report of the disparate roles of CSF-1 and IL-34 in vertebrate antiviral immunity.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  CSF-1; FV3; IL-34; immunity; ranavirus

Mesh:

Substances:

Year:  2014        PMID: 25190077      PMCID: PMC4226796          DOI: 10.1189/jlb.4A0614-295R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

Review 1.  Ranaviruses (family Iridoviridae): emerging cold-blooded killers.

Authors:  V G Chinchar
Journal:  Arch Virol       Date:  2002-03       Impact factor: 2.574

2.  Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.

Authors:  Suwen Wei; Sayan Nandi; Violeta Chitu; Yee-Guide Yeung; Wenfeng Yu; Minmei Huang; Lewis T Williams; Haishan Lin; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2010-05-26       Impact factor: 4.962

3.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

Authors:  Xu-Ming Dai; Gregory R Ryan; Andrew J Hapel; Melissa G Dominguez; Robert G Russell; Sara Kapp; Vonetta Sylvestre; E Richard Stanley
Journal:  Blood       Date:  2002-01-01       Impact factor: 22.113

4.  Transmission of the Ambystoma tigrinum virus to alternative hosts.

Authors:  J K Jancovich; E W Davids; A Seiler; B L Jacobs; J P Collins
Journal:  Dis Aquat Organ       Date:  2001-10-08       Impact factor: 1.802

5.  Experimental infection of Australian freshwater fish with epizootic haematopoietic necrosis virus (EHNV).

Authors:  Joy A Becker; Alison Tweedie; Dean Gilligan; Martin Asmus; Richard J Whittington
Journal:  J Aquat Anim Health       Date:  2013-03       Impact factor: 1.625

6.  Co-infection by alveolate parasites and frog virus 3-like ranavirus during an amphibian larval mortality event in Florida, USA.

Authors:  Jan H Landsberg; Yasunari Kiryu; Maki Tabuchi; Thomas B Waltzek; Kevin M Enge; Sarah Reintjes-Tolen; Asa Preston; Allan P Pessier
Journal:  Dis Aquat Organ       Date:  2013-07-22       Impact factor: 1.802

Review 7.  Interkeukin-34, a cytokine crucial for the differentiation and maintenance of tissue resident macrophages and Langerhans cells.

Authors:  Yaming Wang; Marco Colonna
Journal:  Eur J Immunol       Date:  2014-05-22       Impact factor: 5.532

8.  The amphibian (Xenopus laevis) type I interferon response to frog virus 3: new insight into ranavirus pathogenicity.

Authors:  Leon Grayfer; Francisco De Jesús Andino; Jacques Robert
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

9.  CSF-1 receptor-mediated differentiation of a new type of monocytic cell with B cell-stimulating activity: its selective dependence on IL-34.

Authors:  Fumihiro Yamane; Yumiko Nishikawa; Kazue Matsui; Miki Asakura; Eriko Iwasaki; Koji Watanabe; Hikaru Tanimoto; Hiroki Sano; Yuki Fujiwara; E Richard Stanley; Naoki Kanayama; Neil A Mabbott; Masaki Magari; Hitoshi Ohmori
Journal:  J Leukoc Biol       Date:  2013-09-19       Impact factor: 4.962

10.  Elephant shark genome provides unique insights into gnathostome evolution.

Authors:  Byrappa Venkatesh; Alison P Lee; Vydianathan Ravi; Ashish K Maurya; Michelle M Lian; Jeremy B Swann; Yuko Ohta; Martin F Flajnik; Yoichi Sutoh; Masanori Kasahara; Shawn Hoon; Vamshidhar Gangu; Scott W Roy; Manuel Irimia; Vladimir Korzh; Igor Kondrychyn; Zhi Wei Lim; Boon-Hui Tay; Sumanty Tohari; Kiat Whye Kong; Shufen Ho; Belen Lorente-Galdos; Javier Quilez; Tomas Marques-Bonet; Brian J Raney; Philip W Ingham; Alice Tay; LaDeana W Hillier; Patrick Minx; Thomas Boehm; Richard K Wilson; Sydney Brenner; Wesley C Warren
Journal:  Nature       Date:  2014-01-09       Impact factor: 49.962

View more
  20 in total

1.  Xenopus-FV3 host-pathogen interactions and immune evasion.

Authors:  Robert Jacques; Eva-Stina Edholm; Sanchez Jazz; Torres-Luquis Odalys; De Jesús Andino Francisco
Journal:  Virology       Date:  2017-06-16       Impact factor: 3.616

2.  Differentiation-dependent antiviral capacities of amphibian (Xenopus laevis) macrophages.

Authors:  Amulya Yaparla; Milan Popovic; Leon Grayfer
Journal:  J Biol Chem       Date:  2017-12-19       Impact factor: 5.157

3.  Use of cell lines and primary cultures to explore the capacity of rainbow trout to be a host for frog virus 3 (FV3).

Authors:  P H Pham; Y J Huang; D D Mosser; N C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-05-07       Impact factor: 2.416

4.  Distinct functional roles of amphibian (Xenopus laevis) colony-stimulating factor-1- and interleukin-34-derived macrophages.

Authors:  Leon Grayfer; Jacques Robert
Journal:  J Leukoc Biol       Date:  2015-07-01       Impact factor: 4.962

5.  Nonclassical MHC-Restricted Invariant Vα6 T Cells Are Critical for Efficient Early Innate Antiviral Immunity in the Amphibian Xenopus laevis.

Authors:  Eva-Stina Edholm; Leon Grayfer; Francisco De Jesús Andino; Jacques Robert
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

Review 6.  Immunoregulatory properties of the cytokine IL-34.

Authors:  Carole Guillonneau; Séverine Bézie; Ignacio Anegon
Journal:  Cell Mol Life Sci       Date:  2017-03-03       Impact factor: 9.261

Review 7.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

8.  Mechanisms of amphibian macrophage development: characterization of the Xenopus laevis colony-stimulating factor-1 receptor.

Authors:  Leon Grayfer; Eva-Stina Edholm; Jacques Robert
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 9.  Amphibian macrophage development and antiviral defenses.

Authors:  Leon Grayfer; Jacques Robert
Journal:  Dev Comp Immunol       Date:  2015-12-15       Impact factor: 3.636

10.  Water Temperature Affects Susceptibility to Ranavirus.

Authors:  Mabre D Brand; Rachel D Hill; Roberto Brenes; Jordan C Chaney; Rebecca P Wilkes; Leon Grayfer; Debra L Miller; Matthew J Gray
Journal:  Ecohealth       Date:  2016-06-09       Impact factor: 3.184

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.